ssri
34 interactions related to ssri
St. John's Wort + SSRI
St. John's Wort raises serotonin activity, and SSRI labels (including Zoloft, Prozac, Paxil, Celexa and Lexapro) list it among the products that increase the risk of serotonin syndrome, a potentially life-threatening reaction. It also speeds up CYP3A4 and the transporter P-glycoprotein, which may lower the levels of some antidepressants. Serotonin syndrome has been reported in older adults who combined antidepressants with the herb, so the advice is to avoid the combination.
alcohol + fluoxetine
Fluoxetine (Prozac) is an SSRI antidepressant, and alcohol is a central nervous system depressant. The Prozac Medication Guide, part of the FDA-approved label, says not to drink alcohol while using Prozac. Fluoxetine and its active metabolite norfluoxetine also have unusually long half-lives, so the drug stays in your system for weeks once you reach steady state: there is no simple "timing window" that avoids the interaction. In a small 1988 study of 12 healthy volunteers who took fluoxetine for 7 days, a measured dose of alcohol affected thinking and coordination tests about the same as with placebo. The current label does not report this finding, and the precaution remains sensible but is not an emergency.
paroxetine + tryptophan
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Paxil label says combining paroxetine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. The label for Brisdelle, a low-dose paroxetine, adds that headache, nausea, sweating and dizziness have been reported when tryptophan was given to people taking paroxetine and says the combination is not recommended. No published case of serotonin syndrome with this exact pair was found; the rating follows the labels and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.
coffee + fluvoxamine
Fluvoxamine strongly blocks CYP1A2, the liver enzyme that breaks down caffeine. In 8 healthy volunteers, fluvoxamine cut caffeine clearance by about 80% and stretched its half-life from 5 to 31 hours, so the same coffee builds up to higher, longer-lasting caffeine levels; the study authors warned that caffeine taken during fluvoxamine treatment may lead to caffeine intoxication. Other antidepressants tested in people did not change caffeine clearance (sertraline in 21 patients and volunteers, venlafaxine in 16 healthy adults), so this entry applies to fluvoxamine only.
sertraline + 5-htp
Sertraline blocks serotonin reuptake and 5-HTP (5-hydroxytryptophan) is the immediate precursor of serotonin, so it directly increases serotonin synthesis. Combining the two stacks production and reuptake blockade, which can precipitate serotonin syndrome, a potentially life-threatening reaction. In a published case, a man taking sertraline with a 5-HTP supplement developed serotonin syndrome that progressed to muscle breakdown and acute compartment syndrome needing surgery.
fluoxetine + kava
Kava carries a well-documented risk of serious, unpredictable liver injury and acts as a central nervous system depressant, so combining it with fluoxetine raises concern about additive sedation and liver harm. Lab studies suggested kava might block enzymes that clear fluoxetine, but in healthy volunteers kava taken for 2 to 4 weeks did not slow CYP2D6, the main enzyme that clears fluoxetine, so a rise in fluoxetine levels is not expected.
fluoxetine + tryptophan
Fluoxetine blocks serotonin reuptake while tryptophan supplies the raw material for serotonin synthesis, and the combination can produce an excitatory reaction or serotonin syndrome. Fluoxetine's long-acting active metabolite means this risk persists for weeks after the last dose.
sertraline + kava
Kava (Piper methysticum) is a central nervous system depressant with a documented risk of serious liver injury, and combining it with sertraline raises the chance of additive sedation and additive liver stress. Kava also inhibits drug-metabolizing enzymes, and a case report describes prolonged serotonin syndrome in a patient taking kava alongside a serotonergic antidepressant.
alcohol + citalopram
Current citalopram oral solution labels say citalopram did not increase alcohol's effects on thinking and coordination in a clinical trial, but they still recommend against alcohol in people with depression, and their Medication Guide says not to drink while using citalopram. The current Celexa tablet label no longer carries this advice, so the label basis is weaker than for escitalopram. Citalopram can itself cause sleepiness, and alcohol adds its own impairment; no controlled study has shown that the combination is more harmful.
fluoxetine + saffron
Saffron (Crocus sativus) has its own mild antidepressant activity, including serotonergic effects shown in randomized controlled trials. Combining a standardized saffron extract with fluoxetine theoretically adds to serotonergic tone, but augmentation trials adding saffron on top of existing antidepressants found it well tolerated, with no reported cases of serotonin syndrome. The interaction is best treated as plausible rather than documented.
citalopram + tryptophan
Citalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Celexa label says the risk of serotonin syndrome, a potentially life-threatening reaction, is increased with other serotonergic drugs, and it names tryptophan in the same list as St. John's wort. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with escitalopram, sertraline, fluoxetine and venlafaxine.
fluoxetine + st. john's wort
Fluoxetine and St. John's wort both increase serotonin activity, and the Prozac label lists St. John's wort among the products that raise the risk of serotonin syndrome, a reaction that can be life-threatening. Because fluoxetine stays in the body for weeks, the risk continues after the last dose.
sertraline + st. john's wort
Sertraline is an SSRI that blocks serotonin reuptake, and St. John's wort independently raises central serotonin through constituents such as hyperforin and hypericin. Combining them can trigger serotonin syndrome, a potentially life-threatening reaction marked by altered mental status, autonomic instability, and neuromuscular hyperactivity. St. John's wort also speeds up CYP3A4 and CYP2C19, two of several liver enzymes that break down sertraline, so it could lower sertraline levels, but no study has measured this.
fluoxetine + sam-e
SAM-e has its own serotonergic and mood-elevating activity, so combining it with fluoxetine can add to your overall serotonin tone. In theory this can raise the risk of serotonin syndrome, and in vulnerable people it can tip mood into hypomania or mania. Because fluoxetine clears slowly, this caution lingers for weeks after the last dose. The evidence is mostly case reports involving other antidepressants and general guidance about combining SAM-e with serotonin-raising drugs, rather than fluoxetine-specific data.
paroxetine + 5-htp
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Paxil label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with paroxetine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
citalopram + 5-htp
Citalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Celexa label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with citalopram and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
sertraline + tryptophan
Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin signaling, and L-tryptophan is the dietary precursor your body converts into serotonin. Taking them together can push serotonergic activity too high, raising the risk of serotonin syndrome (agitation, tremor, sweating, fast heart rate, and in severe cases fever, rigidity, and seizures). The sertraline label lists tryptophan among the drugs that raise the risk of this potentially life-threatening reaction.
escitalopram + 5-htp
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Lexapro label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with escitalopram and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
alcohol + fluvoxamine
The fluvoxamine label says studies of alcohol given with fluvoxamine found no effect of either drug on how the body handles the other or on their effects, but it still advises avoiding alcohol, as with other psychotropic medicines, and the Medication Guide says not to drink while using fluvoxamine. Two research groups found, in controlled studies of healthy men, that fluvoxamine did not make alcohol's impairment of thinking, memory or reaction time worse. Fluvoxamine can itself cause sleepiness or slow thinking and reactions, and alcohol adds its own impairment, so the advice rests on general caution rather than a measured clash.
fluvoxamine + 5-htp
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The fluvoxamine label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk and says it may enhance fluvoxamine's effects; it does not name 5-HTP itself. No case with fluvoxamine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
fluvoxamine + tryptophan
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The fluvoxamine label says the risk of serotonin syndrome, a potentially life-threatening reaction, is increased with other serotonergic drugs including tryptophan, and it gives tryptophan its own warning: it may enhance fluvoxamine's serotonin effects, and severe vomiting has been reported with the combination. In 30 depressed patients, fluvoxamine strengthened the body's hormone response to tryptophan given by vein, a sign of a stronger serotonin effect; no controlled study has measured how often harm occurs.
fluvoxamine + melatonin
Fluvoxamine strongly blocks CYP1A2, the liver enzyme that breaks down almost all of the melatonin you swallow. In a small study of 5 healthy men, taking melatonin with fluvoxamine left about 17 times more melatonin in the blood than melatonin alone, and fluvoxamine also raised the body's own nighttime melatonin in other volunteer studies. No study has measured whether this causes harm such as next-day sleepiness, and the fluvoxamine label does not mention melatonin, although it warns against ramelteon, a sleep medicine cleared the same way.
saffron + antidepressants
Saffron's active compounds (crocin and safranal) show antidepressant-like activity in laboratory and animal studies. Proposed mechanisms include blocking the reuptake of serotonin, norepinephrine and dopamine, which overlaps with how most antidepressants work, so in theory saffron could add to their effects. This concern is theoretical. In a placebo-controlled trial in 160 adults already taking an antidepressant (the abstract does not name the drugs), adding a standardized saffron extract for 8 weeks improved clinician-rated depression scores and did not worsen antidepressant side effects; the only trial that names the drugs added crocin to the SSRIs fluoxetine, sertraline or citalopram. No published case of serotonin syndrome from saffron was found.
paroxetine + st. john's wort
Paroxetine is an SSRI that raises serotonin by blocking its reuptake. St. John's wort independently raises serotonin and also speeds up drug-metabolizing enzymes and P-glycoprotein. Taken together, the additive serotonin effect can precipitate serotonin syndrome, a potentially life-threatening reaction, and the paroxetine label lists St. John's Wort among the drugs that raise this risk.
sertraline + sam-e
SAM-e (S-adenosyl-L-methionine) has its own antidepressant and serotonergic activity, so combining it with the SSRI sertraline can add serotonergic effects on top of each other. Case reports describe serotonin-toxicity-like presentations and treatment-emergent mania in patients combining SAM-e with serotonergic antidepressants.
caffeine + sertraline
Caffeine and sertraline do not share a receptor, but their side-effect profiles overlap. Both can cause anxiety, jitteriness, insomnia, stomach upset and headache, so these symptoms can stack, most noticeably during the first few weeks of sertraline treatment. Unlike fluvoxamine, sertraline does not meaningfully slow caffeine clearance.
cbd + sertraline
CBD inhibits CYP2C19, one of several enzymes that help break down sertraline, so adding CBD can raise sertraline exposure. A single published case report describes low sodium (hyponatremia) and cognitive decline in an older intermediate-metabolizer patient who added over-the-counter CBD to long-standing sertraline. The evidence is limited to this one report, so treat it as a reason for caution and prescriber discussion rather than a strong contraindication.
coffee + sertraline
Sertraline has little or no effect on CYP1A2, the liver enzyme that clears caffeine: in a study of 21 people taking it at usual doses, CYP1A2 activity did not change significantly, unlike with fluvoxamine. More relevant in practice, caffeine can add to the jitteriness, palpitations, anxiety, and insomnia that often appear in the first weeks of sertraline.
fluoxetine + 5-htp
Fluoxetine is an SSRI that blocks serotonin reuptake, and 5-HTP is a direct precursor the body converts into serotonin. Combining them can push serotonin to levels associated with serotonin syndrome, and fluoxetine's long-lived active metabolite norfluoxetine extends this risk for weeks after the last dose.
escitalopram + st. john's wort
Escitalopram is an SSRI cleared mainly by CYP2C19 and CYP3A4. St. John's wort independently raises serotonin and speeds up those same enzymes in people. Taken together, the combination can trigger serotonin syndrome, a potentially life-threatening reaction, and the escitalopram label lists St. John's Wort among the drugs that raise this risk. St. John's wort could also lower escitalopram levels, but no study has measured this. Published serotonin syndrome cases involve other antidepressants rather than escitalopram specifically.
cannabis + ssris
CBD, found in many cannabis products, can raise levels of some SSRIs: in lab tests it blocked the CYP2C19 and CYP3A4 breakdown of citalopram and escitalopram, adding CBD raised citalopram levels in 6 patients taking citalopram or escitalopram, and in 20 healthy adults it raised citalopram exposure by about 43%. In the same lab tests CBD barely changed the breakdown of sertraline or fluoxetine, and its potent block of CYP2D6, which clears paroxetine, has been shown only in the lab. Separately, a case report describes repeated serotonin syndrome in a young man taking fluoxetine and lithium, with two episodes starting within hours of using high-THC cannabis oil or a THC vape pen.
alcohol + sertraline
Sertraline (Zoloft) and alcohol both act on the central nervous system. Controlled studies in healthy volunteers did not show sertraline worsening alcohol's effects on thinking or coordination, but the FDA label still advises against drinking on sertraline because alcohol can deepen depression and anxiety, worsen drowsiness and sleep, and blunt the medication's benefit in people being treated for a mood disorder.
alcohol + escitalopram
The Lexapro label says escitalopram did not increase alcohol's effects on thinking and coordination in a clinical trial, but it still recommends against alcohol, and the Medication Guide says not to drink during treatment. Escitalopram can itself cause sleepiness or slow thinking and reactions, and alcohol adds its own impairment. One published case described serotonin syndrome after a can of beer in a man taking escitalopram with a second antidepressant, clomipramine; a single case is a signal, not proof.
escitalopram + tryptophan
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Lexapro label says combining escitalopram with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. Its highlights say use with tryptophan is not recommended. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.
